| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Desjardins Canadian Universe Bond Index ETF declares CAD 0.0463 dividend | ||
| Fr | Philip Morris International shares climb seven straight sessions | ||
| Fr | Mid to low cap healthcare stocks with the strongest earnings momentum | ||
| Fr | Honeywell shares uptick for seven consecutive sessions | ||
| Fr | Dominion wins court OK to resume Virginia offshore wind project stopped by Trump | ||
| Fr | Mega-to-large cap healthcare stocks with the weakest earnings momentum | ||
| Fr | Regions Financial outlines 2026 net interest income growth target of 2.5%-4% as loan pipelines strengthen | ||
| Fr | Netflix streaming turns 19: Remembering the day the iconic red DVD envelope became extinct | ||
| Fr | OpenAI makes low-cost ChatGPT Go plan available worldwide; starts ad testing | ||
| Fr | Genmab down after trial data for AbbVie-partnered Epkinly in B-cell lymphoma | ||
| Fr | The best small and mid-cap real estate companies by earnings momentum | ||
| Fr | Mega-to-large cap healthcare stocks with the strongest earnings momentum | ||
| Fr | TTWO trades in red for seventh straight session | ||
| Fr | Market Voices: Trump, Kremlin on Greenland; Trump on Fed chair nominee | ||
| Fr | Tractor Supply is cut at Truist due to sales growth concerns | ||
| Fr | NextEra Energy set for seven straight sessions of gains | ||
| Fr | Kimberly-Clark acquisition of Kenvue gains ISS recommendation | ||
| Fr | ConocoPhillips cut to Sell equivalent at BofA on high oil breakeven; Ovintiv top oil pick | ||
| Fr | Pnc expects 8% loan growth and 11% revenue increase in 2026 while integrating FirstBank | ||
| Fr | Honeywell upgraded at J.P. Morgan on 'disconnect' to asset value; 3M downgraded | ||
| Fr | U.S. stocks seesaw, even as some chipmakers advance | ||
| Fr | RTX extends rally for seventh straight session | ||
| Fr | SA analyst upgrades/downgrades: ZS, LRCX, NXPI, RKLB | ||
| Fr | Why investors should be more cautious about the markets | ||
| Fr | Novartis wins FDA breakthrough status for Sjögren's disease therapy |